ArticlePloS one2023

A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.

Shyam Nyati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.